z-logo
open-access-imgOpen Access
Sero epidemiology of Bordetella pertussis immune responses in a healthy population in northern Greece
Author(s) -
Polyzou A.,
Pournaras S.,
Dafni U.,
Sofianou D.,
Christeli E.,
Patrinos S.,
Tsakris A.
Publication year - 2004
Publication title -
journal of clinical laboratory analysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.536
H-Index - 50
eISSN - 1098-2825
pISSN - 0887-8013
DOI - 10.1002/jcla.20025
Subject(s) - filamentous haemagglutinin adhesin , epidemiology , medicine , population , booster dose , antibody , post hoc , pertussis toxin , vaccination , pediatrics , immunology , demography , immunization , environmental health , receptor , g protein , sociology
A seroepidemiological study was conducted on a representative sample of the northern Greek population (healthy individuals, age range=1 day to 80 years) to assess the prevalence of antibodies to pertussis toxin (PT) and filamentous hemagglutinin (FHA). Antibody concentrations were significantly elevated with age (analysis of variance (ANOVA), P <0.001). In addition, a significant increase in antibody levels was detected in subjects >50 years old compared to children aged 5–10 years (post‐hoc Scheffe analysis, P =0.007). These data suggest that pertussis occurs frequently in Greek adults, and that sometimes a fifth booster vaccine dose is not given after the second year of life. Routine revaccination with the acellular vaccine for children >4 years of age, adolescents, and adults should be considered in order to ensure effective protection of the whole population. J. Clin. Lab. Anal. 18:211–214, 2004. © 2004 Wiley‐Liss, Inc.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom